Search - tctmd.com

Displaying 501 - 520 of 3565

Sort: Relevancy | Date

Presentation TCT 2022

Conclusion

Presenter: Roxana Mehran

September 17, 2022

Presentation TCT 2022

World’s largest RCT for DM - ABILITY DIABETES GLOBAL: Implication and Importance

Presenter: Marie-Claude Morice

September 17, 2022

Presentation TCT 2022

Diabetes and DES+DCB platform: the perfect match

Presenter: Luca Testa

September 17, 2022

Presentation TCT 2022

The role of imaging in DM patients: case presentations from ABILITY RCT

Presenter: Antonio Mangieri

September 17, 2022

Presentation TCT 2022

The Innovative DES+DCB platform

Presenter: Fazila-Tun-Nesa Malik

September 17, 2022

Presentation TCT 2022

TCT 29: Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients with Diabetes: Results From the PTRG-DES Registry

Presenter: KI-HYUN JEON

September 17, 2022

Presentation TCT 2022

Hybrid Interventional Approach (DCB + DES): Clinical Indications, Available Data and Future Perspectives

Presenter: Bruno Scheller

September 17, 2022

Presentation TCT 2022

Stent-Free PCI (DCB Only Approach): Insights and Considerations from the SELUTION de NOVO Randomized Control Study

Presenter: Christian M. Spaulding

September 17, 2022

Presentation TCT 2022

TCT 56: Long-term outcomes after bioresorbable vascular scaffold implantation in patients with de-novo coronary artery disease.

Presenter: Marta Konopko

September 17, 2022

Presentation TCT 2022

Sirolimus DCBs: Technological Trends, Challenges and Advantages

Presenter: Ron Waksman

September 17, 2022

Presentation TCT 2022

Sirolimus Coated DCB in All-Comers EASTBOURNE (MagicTouch DCB)

Presenter: Bernardo Cortese

September 17, 2022

Presentation TCT 2022

TCT 758: Low Contrast Protected PCI Combining DES and DEB for the Treatment of Severely Calcified Left Main and Multivessel Disease in a High-Risk Patient

Presenter: Ottavia Cozzi

September 17, 2022

Presentation TCT 2022

DCB for SVD: Primary Outcomes of a Multi-Center RCT with AGENT DCB

Presenter: Paul Underwood

September 17, 2022

Presentation TCT 2022

5-Year RESTORE SVD China Trial: Restore DCB vs. DES Resolute Integrity in SVD

Presenter: ShaoLiang Chen

September 17, 2022

Presentation TCT 2022

3-Year Outcome of paclitaxel DCB vs. DES for Native Vessel Disease Treatment: Final Follow Up of the Randomized PICCOLETO II Trial

Presenter: Bernardo Cortese

September 17, 2022

Presentation TCT 2022

Time to Move Beyond ISR – My Vision of the Future for Coronary DCB Technologies

Presenter: Antonio Colombo

September 17, 2022

Presentation TCT 2022

Welcome

Presenter: Desmond Adler

September 17, 2022

Presentation TVT 2022

TVARC Safety and Efficacy Endpoint Recommended for Clinical Trials

Presenter: Mahesh V. Madhavan

June 10, 2022

Presentation TVT 2022

Quality-of-life Assessments and Cost-effectiveness Analyses in TTVI Trials

Presenter: Geraldine Ong, Gilbert H. L. Tang, Yan Topilsky

June 10, 2022

Presentation TVT 2022

Clinical Trial Pathways and Study Designs: Embolic Capture vs Deflection Devices

Presenter: Alexandra Lansky

June 10, 2022

Advertisement

Conclusion

World’s largest RCT for DM - ABILITY DIABETES GLOBAL: Implication and Importance

Diabetes and DES+DCB platform: the perfect match

The role of imaging in DM patients: case presentations from ABILITY RCT

The Innovative DES+DCB platform

TCT 29: Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients with Diabetes: Results From the PTRG-DES Registry

Hybrid Interventional Approach (DCB + DES): Clinical Indications, Available Data and Future Perspectives

Stent-Free PCI (DCB Only Approach): Insights and Considerations from the SELUTION de NOVO Randomized Control Study

TCT 56: Long-term outcomes after bioresorbable vascular scaffold implantation in patients with de-novo coronary artery disease.

Sirolimus DCBs: Technological Trends, Challenges and Advantages

Sirolimus Coated DCB in All-Comers EASTBOURNE (MagicTouch DCB)

TCT 758: Low Contrast Protected PCI Combining DES and DEB for the Treatment of Severely Calcified Left Main and Multivessel Disease in a High-Risk Patient

DCB for SVD: Primary Outcomes of a Multi-Center RCT with AGENT DCB

5-Year RESTORE SVD China Trial: Restore DCB vs. DES Resolute Integrity in SVD

3-Year Outcome of paclitaxel DCB vs. DES for Native Vessel Disease Treatment: Final Follow Up of the Randomized PICCOLETO II Trial

Time to Move Beyond ISR – My Vision of the Future for Coronary DCB Technologies

Welcome

TVARC Safety and Efficacy Endpoint Recommended for Clinical Trials

Quality-of-life Assessments and Cost-effectiveness Analyses in TTVI Trials

Clinical Trial Pathways and Study Designs: Embolic Capture vs Deflection Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content